1. Home
  2. CLDX vs LUNR Comparison

CLDX vs LUNR Comparison

Compare CLDX & LUNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • LUNR
  • Stock Information
  • Founded
  • CLDX N/A
  • LUNR 2013
  • Country
  • CLDX United States
  • LUNR United States
  • Employees
  • CLDX N/A
  • LUNR N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LUNR Industrial Machinery/Components
  • Sector
  • CLDX Health Care
  • LUNR Industrials
  • Exchange
  • CLDX Nasdaq
  • LUNR Nasdaq
  • Market Cap
  • CLDX 1.3B
  • LUNR 1.1B
  • IPO Year
  • CLDX 2008
  • LUNR N/A
  • Fundamental
  • Price
  • CLDX $20.10
  • LUNR $11.83
  • Analyst Decision
  • CLDX Buy
  • LUNR Strong Buy
  • Analyst Count
  • CLDX 9
  • LUNR 6
  • Target Price
  • CLDX $50.00
  • LUNR $15.58
  • AVG Volume (30 Days)
  • CLDX 664.5K
  • LUNR 7.3M
  • Earning Date
  • CLDX 05-08-2025
  • LUNR 05-13-2025
  • Dividend Yield
  • CLDX N/A
  • LUNR N/A
  • EPS Growth
  • CLDX N/A
  • LUNR N/A
  • EPS
  • CLDX N/A
  • LUNR N/A
  • Revenue
  • CLDX $7,559,000.00
  • LUNR $217,305,000.00
  • Revenue This Year
  • CLDX N/A
  • LUNR $21.92
  • Revenue Next Year
  • CLDX N/A
  • LUNR $42.00
  • P/E Ratio
  • CLDX N/A
  • LUNR N/A
  • Revenue Growth
  • CLDX 24.49
  • LUNR 61.52
  • 52 Week Low
  • CLDX $14.40
  • LUNR $3.15
  • 52 Week High
  • CLDX $47.00
  • LUNR $24.95
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 53.76
  • LUNR 72.75
  • Support Level
  • CLDX $18.47
  • LUNR $8.54
  • Resistance Level
  • CLDX $20.42
  • LUNR $12.80
  • Average True Range (ATR)
  • CLDX 1.29
  • LUNR 0.70
  • MACD
  • CLDX -0.02
  • LUNR 0.43
  • Stochastic Oscillator
  • CLDX 60.32
  • LUNR 80.00

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About LUNR Intuitive Machines Inc.

Intuitive Machines Inc is a space exploration, infrastructure, and services company. It is a diversified space company focused on space exploration. It supplies space products and services to support sustained robotic and human exploration to the Moon, Mars, and beyond. Its products and services are offered through its four business units: Lunar Access Services, Orbital Services, Lunar Data Services, and Space Products and Infrastructure. The Company operates in one operating segment and one reportable segment underpinned by three core pillars (delivery services, data transmission services, and infrastructure as a service) that have similar capabilities, customers, and economic characteristics. Revenue is from contracts with customers of orbital and lunar access services.

Share on Social Networks: